These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29151951)

  • 1. Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer.
    Domvri K; Zarogoulidis K; Zogas N; Zarogoulidis P; Petanidis S; Porpodis K; Kioseoglou E; Hohenforst-Schmidt W
    J Cancer; 2017; 8(18):3648-3656. PubMed ID: 29151951
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil enhances cisplatin-induced apoptosis in human breast adenocarcinoma cells.
    Hassanvand F; Mohammadi T; Ayoubzadeh N; Tavakoli A; Hassanzadeh N; Sanikhani NS; Azimi AI; Mirzaei HR; Khodamoradi M; Goudarzi KA; Pourghadamyari H; Zaimy MA
    J Cancer Res Ther; 2020; 16(6):1412-1418. PubMed ID: 33342806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
    Domvri K; Bougiouklis D; Zarogoulidis P; Porpodis K; Xristoforidis M; Liaka A; Eleutheriadou E; Lampaki S; Lazaridis G; Organtzis J; Kyriazis G; Hohenforst-Schmidt W; Tsirgogianni K; Karavasilis V; Baka S; Darwiche K; Freitag L; Trakada G; Zarogoulidis K
    J Cancer; 2015; 6(4):360-6. PubMed ID: 25767606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).
    Zhang BY; Wang YM; Gong H; Zhao H; Lv XY; Yuan GH; Han SR
    Int J Clin Exp Pathol; 2015; 8(1):25-37. PubMed ID: 25755690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in non-small lung carcinoma cell line (H1299) by combination of anti-asthma drugs with gemcitabine and cisplatin.
    Merimsky O; Hirsh L; Dantes A; Land-Bracha A; Suh BS; Amsterdam A
    Int J Oncol; 2005 Feb; 26(2):475-82. PubMed ID: 15645133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
    Zhou Y; Pan DS; Shan S; Zhu JZ; Zhang K; Yue XP; Nie LP; Wan J; Lu XP; Zhang W; Ning ZQ
    Biomed Pharmacother; 2014 May; 68(4):483-91. PubMed ID: 24721323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.
    Franks SE; Jones RA; Briah R; Murray P; Moorehead RA
    BMC Res Notes; 2016 Mar; 9():134. PubMed ID: 26928578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase inhibitors as anti-cancer drugs.
    Hirsh L; Dantes A; Suh BS; Yoshida Y; Hosokawa K; Tajima K; Kotsuji F; Merimsky O; Amsterdam A
    Biochem Pharmacol; 2004 Sep; 68(6):981-8. PubMed ID: 15313391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-cisplatin based chemotherapy in advanced non-small cell lung cancer].
    Hosomi Y; Shibuya M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):527-32. PubMed ID: 17431336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
    Hirsch FR; Osterlind K; Jeppesen N; Dombernowsky P; Ingeberg S; Sorensen PG; Kristensen C; Hansen HH
    Ann Oncol; 2001 May; 12(5):647-53. PubMed ID: 11432623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.
    Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
    JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
    Tang CH; Parham C; Shocron E; McMahon G; Patel N
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological approach to the platinum compounds].
    Sasaki Y
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin.
    Branco H; Oliveira J; Antunes C; Santos LL; Vasconcelos MH; Xavier CPR
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.